Biopharmaceutical leader in the development of treatments for rare diseases
Educated staff about access to therapies for rare diseases in Medicaid. Education about the value of innovative new medicines and the Orphan Drug Act.

H.R. 749: Lower Drug Prices Through Competition Act.

S. 204: Trickett Wendler Right to Try Act of 2017.

H.R. 1628: American Health Care Act.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX